27.96MMarket Cap-762P/E (TTM)
0.920High0.889Low23.20KVolume0.920Open0.920Pre Close21.03KTurnover0.09%Turnover RatioLossP/E (Static)31.32MShares2.60052wk High0.41P/B23.01MFloat Cap0.70552wk Low--Dividend TTM25.78MShs Float5579.991Historical High--Div YieldTTM3.37%Amplitude0.680Historical Low0.906Avg Price1Lot Size
DarioHealth Stock Forum
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals:
Members with depression showed highe...
DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...
DarioHealth Q1 Net Loss $(7.2)M Compared To $(12.8)M YoY
DarioHealth Corp Qtrly Shr Loss $0.20
DarioHealth Q1 Revenue USD 1.791 Million
Moomoo 24/7· 3 mins ago
No comment yet